• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑块型银屑病的系统治疗可改善血管内皮细胞功能:一项前瞻性纵向先导试验的结果。

Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial.

机构信息

Department of Internal Medicine, Clinic of the Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

出版信息

Arch Dermatol Res. 2011 Aug;303(6):381-8. doi: 10.1007/s00403-010-1108-6. Epub 2010 Dec 18.

DOI:10.1007/s00403-010-1108-6
PMID:21170539
Abstract

Severe psoriasis is associated with significant cardiovascular mortality. We therefore investigated the effects of systemic therapy on the cardiovascular risk of psoriasis patients. Thirteen consecutive patients receiving fumaric acid esters were included and followed for 24 weeks both clinically and by means of laboratory monitoring, 10 completed the study. Eight of ten patients showed a PASI-50 response. Two of three patients with clinical insulin resistance (Homeostasis Model Assessment of insulin resistance >2.5) showed normal insulin responsiveness at the end of the study. Clinical improvement was paralleled by a reduction of high-sensitive CRP serum levels (median -25%). There was a trend toward reduced serum levels for the vascular endothelial growth factor (median -10%) and resistin (median -4%), while the potentially cardio-protective adiponectin showed a trend toward increased serum levels under therapy (median +19%). Systemic endothelial function assessed by venous occlusion plethysmography revealed an improvement of endothelial vasodilator function after 24 weeks of treatment (p < 0.02). This is the first prospective study documenting an amelioration of endothelial cell function in patients with moderate-to-severe plaque-type psoriasis under effective continuous systemic therapy. Future studies need to compare the cardioprotective effects of different treatment modalities, based on hard end points such as the rate of myocardial infarction.

摘要

严重的银屑病与显著的心血管死亡率相关。因此,我们研究了全身治疗对银屑病患者心血管风险的影响。纳入了 13 例连续接受菝葜酸酯治疗的患者,并进行了 24 周的临床和实验室监测随访,10 例完成了研究。10 例患者中有 8 例达到 PASI-50 应答。3 例有临床胰岛素抵抗(稳态模型评估的胰岛素抵抗>2.5)的患者中,有 2 例在研究结束时胰岛素反应正常。临床改善与高敏 CRP 血清水平的降低(中位数-25%)平行。血管内皮生长因子(中位数-10%)和抵抗素(中位数-4%)的血清水平呈下降趋势,而潜在的心脏保护作用的脂联素在治疗过程中呈上升趋势(中位数+19%)。通过静脉闭塞容积描记法评估的全身内皮功能显示,治疗 24 周后内皮血管舒张功能得到改善(p<0.02)。这是第一项前瞻性研究,证明了在有效的连续全身治疗下,中重度斑块型银屑病患者的内皮细胞功能得到改善。未来的研究需要根据心肌梗死等硬终点来比较不同治疗方式的心脏保护作用。

相似文献

1
Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial.斑块型银屑病的系统治疗可改善血管内皮细胞功能:一项前瞻性纵向先导试验的结果。
Arch Dermatol Res. 2011 Aug;303(6):381-8. doi: 10.1007/s00403-010-1108-6. Epub 2010 Dec 18.
2
Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study.系统治疗中重度斑块状银屑病男性患者的性激素谱变化:一项前瞻性纵向研究的初步结果。
Arch Dermatol Res. 2011 Aug;303(6):417-24. doi: 10.1007/s00403-011-1157-5. Epub 2011 Jun 10.
3
Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.严重斑块型银屑病的有效持续系统治疗伴随着心血管风险生物标志物的改善:一项前瞻性纵向观察研究的结果。
J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1187-93. doi: 10.1111/j.1468-3083.2010.03947.x. Epub 2011 Jan 17.
4
Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.富马酸酯对银屑病患者心血管危险因素及抑郁的影响:一项前瞻性初步研究。
Arch Dermatol Res. 2015 Jul;307(5):413-24. doi: 10.1007/s00403-015-1541-7. Epub 2015 Feb 4.
5
Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy.微透析记录了在持续全身治疗下银屑病斑块微环境的变化。
Exp Dermatol. 2011 Feb;20(2):130-3. doi: 10.1111/j.1600-0625.2010.01212.x.
6
Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.急性冠状动脉综合征患者全身内皮功能障碍的预后价值:“易损”患者存在的进一步证据
Circulation. 2004 Oct 5;110(14):1926-32. doi: 10.1161/01.CIR.0000143378.58099.8C. Epub 2004 Sep 27.
7
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.依那西普对银屑病及银屑病关节炎患者C反应蛋白水平的影响。
Br J Dermatol. 2008 Aug;159(2):322-30. doi: 10.1111/j.1365-2133.2008.08628.x. Epub 2008 May 22.
8
Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease.长期服用尼可地尔对无冠心病患者内皮功能、炎症及氧化应激的影响
J Cardiovasc Pharmacol. 2008 Mar;51(3):311-6. doi: 10.1097/FJC.0b013e318163a95f.
9
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.低剂量英夫利昔单抗联合稳定剂量甲氨蝶呤治疗对银屑病皮肤和滑膜中内皮细胞失活及血管生成减少的影响:一项前瞻性单中心研究
Arthritis Res Ther. 2004;6(4):R326-34. doi: 10.1186/ar1182. Epub 2004 May 26.
10
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.葡萄籽提取物对高心血管风险 2 型糖尿病患者的影响:一项双盲随机安慰剂对照试验,观察代谢标志物、血管张力、炎症、氧化应激和胰岛素敏感性。
Diabet Med. 2009 May;26(5):526-31. doi: 10.1111/j.1464-5491.2009.02727.x.

引用本文的文献

1
Psoriasis in Obese Adolescents with Diabetes-From Common Molecular Background to Vicious Circle of Metabolic Syndrome-Case Report and Review of Literature.肥胖青少年糖尿病患者的银屑病——从共同分子背景到代谢综合征恶性循环——病例报告及文献综述
Cells. 2025 Apr 17;14(8):610. doi: 10.3390/cells14080610.
2
Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-α, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort study.接受靶向TNF-α、IL-12/23、IL-17和IL-23生物制剂治疗的银屑病患者的心血管疾病风险:一项基于人群的回顾性队列研究。
PLoS Med. 2025 Apr 17;22(4):e1004591. doi: 10.1371/journal.pmed.1004591. eCollection 2025 Apr.
3
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis.
与传统抗银屑病药物或阿普米司特不同,生物治疗可降低银屑病患者的死亡风险和心血管疾病风险。
EBioMedicine. 2025 Jan;111:105485. doi: 10.1016/j.ebiom.2024.105485. Epub 2024 Dec 6.
4
Psoriasis comorbid with atherosclerosis meets in lipid metabolism.银屑病合并动脉粥样硬化在脂质代谢方面存在交集。
Front Pharmacol. 2023 Dec 11;14:1308965. doi: 10.3389/fphar.2023.1308965. eCollection 2023.
5
Endothelial Dysfunction in Psoriasis: An Updated Review.银屑病中的内皮功能障碍:最新综述
Front Med (Lausanne). 2022 Jun 10;9:864185. doi: 10.3389/fmed.2022.864185. eCollection 2022.
6
Psoriasis and Atherosclerosis-Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics.银屑病与动脉粥样硬化——与生物制剂治疗相关的两种斑块在皮肤、关节和心血管方面的故事。
Int J Mol Sci. 2021 Sep 27;22(19):10402. doi: 10.3390/ijms221910402.
7
Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows.银屑病、心血管事件和生物制剂:利弊共存。
Front Immunol. 2018 Aug 13;9:1668. doi: 10.3389/fimmu.2018.01668. eCollection 2018.
8
Potential Immunological Links Between Psoriasis and Cardiovascular Disease.银屑病与心血管疾病之间潜在的免疫学联系。
Front Immunol. 2018 Jun 1;9:1234. doi: 10.3389/fimmu.2018.01234. eCollection 2018.
9
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.系统性炎症与银屑病患者心血管共病:病因与后果。
Front Immunol. 2018 Apr 5;9:579. doi: 10.3389/fimmu.2018.00579. eCollection 2018.
10
Fumaric acid esters in the management of psoriasis.富马酸酯类药物在银屑病治疗中的应用
Psoriasis (Auckl). 2015 Jan 5;5:9-23. doi: 10.2147/PTT.S51490. eCollection 2015.